Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 798

1.

Prothrombotic factors and the risk of acute onset non-cardioembolic stroke in young Asian Indians.

Biswas A, Ranjan R, Meena A, Akhter S, Sharma V, Yadav BK, Behari M, Saxena R.

Thromb Res. 2009 Sep;124(4):397-402. doi: 10.1016/j.thromres.2009.02.015. Epub 2009 Jun 27.

PMID:
19560187
2.

Factor V Leiden: is it the chief contributor to activated protein C resistance in Asian-Indian patients with deep vein thrombosis?

Biswas A, Bajaj J, Ranjan R, Meena A, Akhter MS, Yadav BK, Sharma V, Saxena R.

Clin Chim Acta. 2008 Jun;392(1-2):21-4. doi: 10.1016/j.cca.2008.02.018. Epub 2008 Feb 25.

PMID:
18342013
3.

Factor V Leiden, prothrombin gene mutation, and thrombosis risk in patients with antiphospholipid antibodies.

Chopra N, Koren S, Greer WL, Fortin PR, Rauch J, Fortin I, Senécal JL, Docherty P, Hanly JG.

J Rheumatol. 2002 Aug;29(8):1683-8.

PMID:
12180730
4.

Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.

Karttunen V, Hiltunen L, Rasi V, Vahtera E, Hillbom M.

Blood Coagul Fibrinolysis. 2003 Apr;14(3):261-8.

PMID:
12695749
5.

Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.

Rahimi Z, Vaisi-Raygani A, Nagel RL, Muniz A.

J Thromb Thrombolysis. 2008 Jun;25(3):288-92. Epub 2007 Jul 11.

PMID:
17619828
7.

Prevalence of factor V Leiden and prothrombin G20210A mutations in Chinese patients with deep venous thrombosis and pulmonary embolism.

Jun ZJ, Ping T, Lei Y, Li L, Ming SY, Jing W.

Clin Lab Haematol. 2006 Apr;28(2):111-6.

PMID:
16630215
8.

Prothrombotic mutations as risk factors for cryptogenic ischemic cerebrovascular events in young subjects with patent foramen ovale.

Botto N, Spadoni I, Giusti S, Ait-Ali L, Sicari R, Andreassi MG.

Stroke. 2007 Jul;38(7):2070-3. Epub 2007 May 24.

9.

Matched case-control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years.

Lalouschek W, Schillinger M, Hsieh K, Endler G, Tentschert S, Lang W, Cheng S, Mannhalter C.

Stroke. 2005 Jul;36(7):1405-9. Epub 2005 Jun 9.

10.

Lower contribution of factor V Leiden or G202104 mutations to ischemic stroke in patients with clinical risk factors: pair-matched case-control study.

Eterović D, Titlić M, Culić V, Zadro R, Primorac D.

Clin Appl Thromb Hemost. 2007 Apr;13(2):188-93.

PMID:
17456629
11.

[Significance of Factor V gene A506G mutation (Leiden) in the pathogenesis of ischemic stroke].

Pongrácz E, Tordai A, Csornai M, Béla Z, Nagy Z.

Ideggyogy Sz. 2003 May 20;56(5-6):157-64. Hungarian.

PMID:
12861956
12.

Association of factor V Leiden mutation with delayed graft function, acute rejection episodes and long-term graft dysfunction in kidney transplant recipients.

Hocher B, Slowinski T, Hauser I, Vetter B, Fritsche L, Bachert D, Kulozik A, Neumayer HH.

Thromb Haemost. 2002 Feb;87(2):194-8.

PMID:
11858477
13.

Survey of factor V leiden and prothrombin gene mutations in systemic lupus erythematosus.

Topaloglu R, Akierli C, Bakkaloglu A, Aydintug O, Ozen S, Besbas N, Ozcelik T.

Clin Rheumatol. 2001;20(4):259-61.

PMID:
11529632
14.

Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.

Sartori MT, Simioni P, Patrassi GM, Theodoridis P, Tormene D, Girolami A.

Clin Appl Thromb Hemost. 2000 Jan;6(1):36-40.

PMID:
10726047
15.

[Prothrombotic factors in stroke].

Meseguer E, Llamas P, Fernández de Velasco J, García A, Echevarria A, Oña R, Rábano J, Tomas JF, García de Yébenes J.

Neurologia. 2004 Apr;19(3):99-105. Spanish.

PMID:
15088159
16.

Symptomatic ischemic stroke in full-term neonates : role of acquired and genetic prothrombotic risk factors.

Günther G, Junker R, Sträter R, Schobess R, Kurnik K, Heller C, Kosch A, Nowak-Göttl U; Childhood Stroke Study Group.

Stroke. 2000 Oct;31(10):2437-41. Erratum in: Stroke 2001 Jan;32(1):279.

17.

Prevalence of hyperhomocysteinaemia, activated protein C resistance and prothrombin gene mutation in inflammatory bowel disease.

Mahmood A, Needham J, Prosser J, Mainwaring J, Trebble T, Mahy G, Ramage J.

Eur J Gastroenterol Hepatol. 2005 Jul;17(7):739-44.

PMID:
15947551
18.

Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India.

Sharma S, Kumar SI, Poddar U, Yachha SK, Aggarwal R.

Indian J Gastroenterol. 2006 Sep-Oct;25(5):236-9.

PMID:
17090840
19.

Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.

El-Karaksy H, El-Koofy N, El-Hawary M, Mostafa A, Aziz M, El-Shabrawi M, Mohsen NA, Kotb M, El-Raziky M, El-Sonoon MA, A-Kader H.

Ann Hematol. 2004 Nov;83(11):712-5. Epub 2004 Aug 10. Erratum in: Ann Hematol. 2005 Mar;84(3):205.

PMID:
15309526
20.

Factor V Leiden and prothrombin gene G20210A mutations in ocular Behçet disease.

Batioğlu F, Atmaca LS, Karabulut HG, Beyza Sayin D.

Acta Ophthalmol Scand. 2003 Jun;81(3):283-5.

Items per page

Supplemental Content

Write to the Help Desk